HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative.

Abstract
Subacute cutaneous lupus erythematosus (SCLE) is a common manifestation of systemic lupus erythematosus. In many cases it appears to be resistant to various systemic or topical treatments. Three cases of resistant SCLE with good response to intravenous immunoglobulin (IVIG) are described here suggesting that IVIG could be an alternative treatment in these patients.
AuthorsChristos E Lampropoulos, Graham R V Hughes, David P D' Cruz
JournalClinical rheumatology (Clin Rheumatol) Vol. 26 Issue 6 Pg. 981-3 (Jun 2007) ISSN: 0770-3198 [Print] Germany
PMID16670831 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulins, Intravenous
  • Immunologic Factors
Topics
  • Adult
  • Female
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Immunologic Factors (therapeutic use)
  • Lupus Erythematosus, Discoid (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: